circulating micrornas as mrd biomarkers in pediatric all
Published 4 years ago • 63 plays • Length 5:19Download video MP4
Download video MP3
Similar videos
-
3:22
the impact of mrd as a biomarker
-
2:25
master final analysis: quadruplet induction therapy, asct & mrd-adapted treatment cessation in ndmm
-
1:23
the value of mrd as a marker for disease eradication in aml
-
1:32
methods to evaluate mrd in aml
-
2:25
jairus ibabao, md | medical oncology and hematology
-
2:22
next-generation methodologies: the future for mrd monitoring in all?
-
0:44
the clinical meaning of mrd below the threshold of mcr in aml
-
1:39
the mechanism of action of navtemadlin and its role in mf
-
2:35
mrd focus: why measurable residual disease testing is the future
-
2:05
mrd in aml clinical practice
-
1:09
dec-c plus venetoclax in hr-mds and cmml: an analysis using different response criteria
-
4:22
the role of mrd in aml
-
1:38
using mrd as an endpoint in clinical trials
-
1:46
standardization mrd monitoring in clinical trials
-
2:18
the utility of measurable residual disease (mrd) assessment in acute myeloid leukemia (aml)
-
1:30
the clinical application of mrd testing in aml
-
1:19
single-cell sequencing of circulating tumor cells to predict progression from mgus/smm
-
1:06
mrd evaluation by mfc and ngs for mm